The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2024 | The transformation of marginal zone lymphoma to Hodgkin lymphoma
Izidore Lossos, MD, University of Miami, Miami, FL, discusses the transformation of marginal zone lymphoma (MZL) into Hodgkin lymphoma, emphasizing its late onset, which often leads to poorer outcomes due to a patient’s inability to tolerate more aggressive therapies. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
